Rifaximin as a rare cause of rhabdomyolysis in cirrhosis

Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezigh, Alec B., Armenia, Erin, Li, Ting, Soesilo, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028404/
https://www.ncbi.nlm.nih.gov/pubmed/29988652
http://dx.doi.org/10.1002/ccr3.1583
_version_ 1783336754272534528
author Rezigh, Alec B.
Armenia, Erin
Li, Ting
Soesilo, Irene
author_facet Rezigh, Alec B.
Armenia, Erin
Li, Ting
Soesilo, Irene
author_sort Rezigh, Alec B.
collection PubMed
description Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be recognized.
format Online
Article
Text
id pubmed-6028404
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60284042018-07-09 Rifaximin as a rare cause of rhabdomyolysis in cirrhosis Rezigh, Alec B. Armenia, Erin Li, Ting Soesilo, Irene Clin Case Rep Case Reports Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be recognized. John Wiley and Sons Inc. 2018-05-27 /pmc/articles/PMC6028404/ /pubmed/29988652 http://dx.doi.org/10.1002/ccr3.1583 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Rezigh, Alec B.
Armenia, Erin
Li, Ting
Soesilo, Irene
Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title_full Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title_fullStr Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title_full_unstemmed Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title_short Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
title_sort rifaximin as a rare cause of rhabdomyolysis in cirrhosis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028404/
https://www.ncbi.nlm.nih.gov/pubmed/29988652
http://dx.doi.org/10.1002/ccr3.1583
work_keys_str_mv AT rezighalecb rifaximinasararecauseofrhabdomyolysisincirrhosis
AT armeniaerin rifaximinasararecauseofrhabdomyolysisincirrhosis
AT liting rifaximinasararecauseofrhabdomyolysisincirrhosis
AT soesiloirene rifaximinasararecauseofrhabdomyolysisincirrhosis

Ejemplares similares